We are live on ! Find out more
LSA

L & S Advisors Portfolio holdings

AUM $795M
1-Year Est. Return 52.77%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+52.77%
3 Year Est. Return
+187.16%
5 Year Est. Return
+324.2%
10 Year Est. Return
+1,741.32%
AUM
$251M
AUM Growth
+$63.7M
Cap. Flow
+$47.8M
Cap. Flow %
19.04%
Top 10 Hldgs %
44.41%
Holding
104
New
24
Increased
40
Reduced
18
Closed
22

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.02M
2
MMM icon
3M
MMM
+$4.44M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$4.1M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$4.04M
5
HAL icon
Halliburton
HAL
+$3.91M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.73M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.49M
3
QCOM icon
Qualcomm
QCOM
+$2.27M
4
KLAC icon
KLA
KLAC
+$2.25M
5
AMGN icon
Amgen
AMGN
+$2.13M

Sector Composition

Rank Sector Weight
1 Communication Services 23.8%
2 Energy 17.91%
3 Industrials 17.42%
4 Healthcare 13.85%
5 Materials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
101
DELISTED
Allergan plc
AGN
– –
-10,023
Closed -$2.06M
SWFT
102
DELISTED
Swift Transportation Company
SWFT
– –
-84,150
Closed -$2.08M
1 2 3 4
5

Similar funds

Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
ACM
Atika Capital Management New York $796M AUM 167.57% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return

L & S Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, L & S Advisors held 104 positions worth $251M, up 34% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

L & S Advisors deployed $47.8M of net new capital in Q2 2014, opening 24 new positions and adding to 40 existing holdings. Its largest new stake was AbbVie: 114,721 shares worth $6.47M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 29% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $3.73M trimmed.

  • L & S Advisors's largest Q2 2014 buy was AbbVie: 114,721 shares worth $6.47M.
  • L & S Advisors added most to KRAFT FOODS GROUP INC COM STK (VA) in Q2 2014, an estimated $4.1M increase.
  • L & S Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $3.73M.
  • L & S Advisors fully exited Bristol-Myers Squibb in Q2 2014, selling an estimated $2.49M.
  • L & S Advisors's ten largest holdings make up 44% of its $251M portfolio in Q2 2014.
  • L & S Advisors opened 24 new positions and closed 22 in Q2 2014.
  • L & S Advisors's portfolio value rose 34% quarter-over-quarter to $251M.

Based on L & S Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.